Genprex raised $6.4 million in IPO at a share price of $5.
Unlike most of the commercial blockbuster lung cancer immunotherapies, its unique lead candidate, Oncoprex® targets advanced lung cancer treatment.
Israeli startup Nutrino raised $8 million in their Series A funding round led by the existing investor New York Angels. According to the Medgenera report, the investment funding in health analytics is estimated to reach around $4.4 billion in 2018 at about 65.7% CAGR during 2015-2018.
Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.